Can you provide the last earnings date for JAZZ PHARMACEUTICALS PLC?
JAZZ PHARMACEUTICALS PLC (JAZZ) last reported earnings on 2/24/2026.
JAZZ PHARMACEUTICALS PLC (JAZZ) Earnings History & Surprises
NASDAQ:JAZZ • IE00B4Q5ZN47
Current stock price
181.37 USD
-0.65 (-0.36%)
At close:
181 USD
-0.37 (-0.2%)
After Hours:
JAZZ Earnings overview
Past quarterly earnings results for JAZZ PHARMACEUTICALS PLC (JAZZ), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $4.63
- Revenue Estimate
- 1.001B
Last Reported
Most Recent- Release Date
- Feb 24, 2026
- Period
- Q4 / 2025
- EPS Reported
- $6.64
- EPS Surprise
- -0.11%
- Revenue Surprise
- 0.75%
Beat Rate
Last 8 Quarters 31%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 6.64 | 6.65 | -0.11% | 0.61% | 1.198B | 1.189B | 0.75% | 10.09% |
| Q3 2025 | 8.13 | 6.04 | 34.65% | 23.00% | 1.126B | 1.131B | -0.43% | 6.74% |
| Q2 2025 | -8.25 | -7.76 | -6.35% | -255.66% | 1.046B | 1.068B | -2.09% | 2.14% |
| Q1 2025 | 1.68 | 4.75 | -64.64% | -37.31% | 897.841M | 1.005B | -10.66% | -0.46% |
| Q4 2024 | 6.60 | 5.93 | 11.32% | 31.47% | 1.088B | 1.081B | 0.66% | 7.53% |
| Q3 2024 | 6.61 | 5.61 | 17.85% | 36.57% | 1.055B | 1.057B | -0.19% | 8.52% |
| Q2 2024 | 5.30 | 4.87 | 8.88% | 17.52% | 1.024B | 1.024B | -0.02% | 6.95% |
| Q1 2024 | 2.68 | 4.26 | -37.13% | -32.15% | 901.983M | 972.97M | -7.30% | 1.03% |
| Q4 2023 | 5.02 | 5.29 | -5.07% | 7,271.43% | 1.012B | 1.021B | -0.89% | 4.10% |
| Q3 2023 | 4.84 | 5.03 | -3.79% | -6.38% | 972.14M | 985.21M | -1.33% | 3.34% |
| Q2 2023 | 4.51 | 4.52 | -0.23% | 4.88% | 957.317M | 961.72M | -0.46% | 2.62% |
| Q1 2023 | 3.95 | 4.32 | -8.66% | 5.90% | 892.812M | 913.34M | -2.25% | 9.72% |
| Q4 2022 | -0.07 | 0.33 | -121.41% | -101.66% | 972.1M | 995.11M | -2.31% | 8.41% |
| Q3 2022 | 5.17 | 4.75 | 8.75% | 23.10% | 940.7M | 957.84M | -1.79% | 12.24% |
| Q2 2022 | 4.30 | 4.28 | 0.58% | 10.26% | 932.9M | 922.3M | 1.15% | 24.09% |
| Q1 2022 | 3.73 | 3.92 | -4.77% | -4.85% | 813.7M | 869.81M | -6.45% | 33.92% |
| Q4 2021 | 4.21 | 3.72 | 13.31% | 5.25% | 896.7M | 881.51M | 1.72% | 34.74% |
| Q3 2021 | 4.20 | 3.38 | 24.08% | -2.55% | 838.1M | 849.17M | -1.30% | 39.47% |
| Q2 2021 | 3.90 | 3.50 | 11.45% | 5.12% | 751.8M | 754.36M | -0.34% | 33.68% |
| Q1 2021 | 3.92 | 3.79 | 3.53% | 771.11% | 607.6M | 620.41M | -2.06% | 13.63% |
| Q4 2020 | 4.00 | 4.29 | -6.69% | - | 665.5M | 652.34M | 2.02% | - |
| Q3 2020 | 4.31 | 4.16 | 3.67% | - | 600.9M | 589.13M | 2.00% | - |
| Q2 2020 | 3.71 | 3.17 | 16.86% | - | 562.4M | 514.75M | 9.26% | - |
| Q1 2020 | 0.45 | 0.69 | -34.35% | - | 534.7M | 555.44M | -3.73% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-6.25%
Max EPS beat (4)
34.65%
Min EPS beat (4)
-64.64%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-3.13%
Max Revenue beat (4)
0.66%
Min Revenue beat (4)
-10.66%
Analysis
In the last 4 quarters, JAZZ has beaten EPS estimates in 2 out of 4 releases
JAZZ has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, JAZZ reported -6.3% below the EPS estimates on average.
In the last 4 quarters, JAZZ reported -3.1% below the revenue estimates on average.
Related analysis
JAZZ PHARMACEUTICALS PLC / JAZZ Earnings FAQ
Can you provide information on whether JAZZ PHARMACEUTICALS PLC beat earnings estimates in the last quarter?
JAZZ PHARMACEUTICALS PLC (JAZZ) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often JAZZ PHARMACEUTICALS PLC beats earnings estimates?
In the last 4 quarters, JAZZ PHARMACEUTICALS PLC (JAZZ) has beaten EPS estimates in 2 out of 4 releases.